cesarean. Delivery by elective caesarean section
Conditions
Interventions
Intervention 1: Patients in placebo group received 0.5% bupivacaine (10 mg) and 0.5 mL of normal saline without preservative (total volume 2.5 ml) for spinal anesthesia. Intervention 2: Patients in in
Placebo
Treatment - Drugs
Patients in placebo group received 0.5% bupivacaine (10 mg) and 0.5 mL of normal saline without preservative (total volume 2.5 ml) for spinal anesthesia.
Patients in intervention group 1 received 0.5% bupivacaine (10 mg) and dexmedetomidine 5 micrograms (Origin orion pharma Germany) (total volume 2.5 ml) for spinal anesthesia.
Patients in intervention group 2 received 0.5% bupivacaine (10 mg) and 10 mg of meperidine (total volume 2.5 ml) for spinal anesthesia.
Sponsors
Shiraz University of Medical Science
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: pregnant women ASA I-II; singleton pregnancies; elective Caesarean section; term neonate; no contraindication for spinal anesthesia. Exclusion criteria :heart diseases; liver diseases; renal failure; coagulopathy; sensitivity to drugs; lack of consent; spinal anesthesia contraindication;a history of seizures; neurological diseases;(IUGR)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The duration of sensory block. Timepoint: Perioperative every 20 min and Post-operative 10 min after arrival to the recovery room. Method of measurement: Pinprick. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Zarghami
Shiraz University of Medical Sciences
Outcome results
None listed